Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shingo Nakayamada

Showing results (1-10 of 224) with videos related to

Pageof 23
Sort By:
Expert Review of Clinical Immunology|September 1, 2021
Clinical relevance of T follicular helper cells in systemic lupus erythematosusShingo Nakayamada, Yoshiya Tanaka
Biomolecules|June 28, 2023
Immune Phenotype as a Biomarker for Systemic Lupus ErythematosusShingo Nakayamada, Yoshiya Tanaka
Frontiers in Immunology|March 15, 2021
Multi-Source Pathways of T Follicular Helper Cell DifferentiationXiaoxue Ma, Shingo Nakayamada
Modern Rheumatology|August 19, 2022
Development of targeted therapies in IgG4-related diseaseShingo Nakayamada, Yoshiya Tanaka
Inflammation and Regeneration|December 21, 2017
BAFF- and APRIL-targeted therapy in systemic autoimmune diseasesShingo Nakayamada, Yoshiya Tanaka
Expert Review of Clinical Immunology|February 9, 2022
Pathological relevance and treatment perspective of JAK targeting in systemic lupus erythematosusShingo Nakayamada, Yoshiya Tanaka
Expert Opinion on Investigational Drugs|September 27, 2023
Novel JAK inhibitors under investigation for systemic lupus erythematosus: - where are we now?Shingo Nakayamada, Yoshiya Tanaka
Clinical Calcium|November 27, 2015
[Anti-RANKL antibody for the treatment of bone and cartilage destruction in rheumatoid arthritis]Shingo Nakayamada, Yoshiya Tanaka
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|May 17, 2016
T follicular helper (Tfh) cells in autoimmune diseasesShingo Nakayamada, Yoshiya Tanaka
Clinical Calcium|May 8, 2018
[Diagnosis and treatment of rheumatoid arthritis:toward the best practice. Change in immune phenotype by the treatment of rheumatoid arthritis.]Shingo Nakayamada, Yoshiya Tanaka
Pageof 23

Showing results (1-10 of 224) with videos related to

Sort By:
Pageof 23
Expert Review of Clinical Immunology|September 1, 2021
Clinical relevance of T follicular helper cells in systemic lupus erythematosusShingo Nakayamada, Yoshiya Tanaka
Biomolecules|June 28, 2023
Immune Phenotype as a Biomarker for Systemic Lupus ErythematosusShingo Nakayamada, Yoshiya Tanaka
Frontiers in Immunology|March 15, 2021
Multi-Source Pathways of T Follicular Helper Cell DifferentiationXiaoxue Ma, Shingo Nakayamada
Modern Rheumatology|August 19, 2022
Development of targeted therapies in IgG4-related diseaseShingo Nakayamada, Yoshiya Tanaka
Inflammation and Regeneration|December 21, 2017
BAFF- and APRIL-targeted therapy in systemic autoimmune diseasesShingo Nakayamada, Yoshiya Tanaka
Expert Review of Clinical Immunology|February 9, 2022
Pathological relevance and treatment perspective of JAK targeting in systemic lupus erythematosusShingo Nakayamada, Yoshiya Tanaka
Expert Opinion on Investigational Drugs|September 27, 2023
Novel JAK inhibitors under investigation for systemic lupus erythematosus: - where are we now?Shingo Nakayamada, Yoshiya Tanaka
Clinical Calcium|November 27, 2015
[Anti-RANKL antibody for the treatment of bone and cartilage destruction in rheumatoid arthritis]Shingo Nakayamada, Yoshiya Tanaka
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|May 17, 2016
T follicular helper (Tfh) cells in autoimmune diseasesShingo Nakayamada, Yoshiya Tanaka
Clinical Calcium|May 8, 2018
[Diagnosis and treatment of rheumatoid arthritis:toward the best practice. Change in immune phenotype by the treatment of rheumatoid arthritis.]Shingo Nakayamada, Yoshiya Tanaka
Pageof 23